These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15585925)

  • 1. Designing TCR for cancer immunotherapy.
    Voss RH; Kuball J; Theobald M
    Methods Mol Med; 2005; 109():229-56. PubMed ID: 15585925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
    Tsuji T; Yoneda A; Matsuzaki J; Miliotto A; Ryan C; Koya RC; Odunsi K
    Cancer Immunol Res; 2018 May; 6(5):594-604. PubMed ID: 29588318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
    Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
    Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System.
    Puig-Saus C; Parisi G; Garcia-Diaz A; Krystofinski PE; Sandoval S; Zhang R; Champhekar AS; McCabe J; Cheung-Lau GC; Truong NA; Vega-Crespo A; Komenan MDS; Pang J; Macabali MH; Saco JD; Goodwin JL; Bolon B; Seet CS; Montel-Hagen A; Crooks GM; Hollis RP; Campo-Fernandez B; Bischof D; Cornetta K; Gschweng EH; Adelson C; Nguyen A; Yang L; Witte ON; Baltimore D; Comin-Anduix B; Kohn DB; Wang X; Cabrera P; Kaplan-Lefko PJ; Berent-Maoz B; Ribas A
    Clin Cancer Res; 2019 Feb; 25(3):1000-1011. PubMed ID: 30409823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer.
    Scholten KB; Schreurs MW; Ruizendaal JJ; Kueter EW; Kramer D; Veenbergen S; Meijer CJ; Hooijberg E
    Clin Immunol; 2005 Feb; 114(2):119-29. PubMed ID: 15639645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular immunology lessons from therapeutic T-cell receptor gene transfer.
    Thomas S; Stauss HJ; Morris EC
    Immunology; 2010 Feb; 129(2):170-7. PubMed ID: 20561357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR.
    Cohen CJ; Zheng Z; Bray R; Zhao Y; Sherman LA; Rosenberg SA; Morgan RA
    J Immunol; 2005 Nov; 175(9):5799-808. PubMed ID: 16237072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors.
    Gladow M; Uckert W; Blankenstein T
    Eur J Immunol; 2004 Jul; 34(7):1882-91. PubMed ID: 15214036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
    Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.
    Chheda ZS; Kohanbash G; Okada K; Jahan N; Sidney J; Pecoraro M; Yang X; Carrera DA; Downey KM; Shrivastav S; Liu S; Lin Y; Lagisetti C; Chuntova P; Watchmaker PB; Mueller S; Pollack IF; Rajalingam R; Carcaboso AM; Mann M; Sette A; Garcia KC; Hou Y; Okada H
    J Exp Med; 2018 Jan; 215(1):141-157. PubMed ID: 29203539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution.
    Alajez NM; Schmielau J; Alter MD; Cascio M; Finn OJ
    Blood; 2005 Jun; 105(12):4583-9. PubMed ID: 15746083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients.
    Arnaud M; Bobisse S; Chiffelle J; Harari A
    Front Immunol; 2021; 12():701636. PubMed ID: 34394096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen.
    Cole DJ; Weil DP; Shilyansky J; Custer M; Kawakami Y; Rosenberg SA; Nishimura MI
    Cancer Res; 1995 Feb; 55(4):748-52. PubMed ID: 7531614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression.
    Voss RH; Kuball J; Engel R; Guillaume P; Romero P; Huber C; Theobald M
    Immunol Res; 2006; 34(1):67-87. PubMed ID: 16720899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid identification and expression of human TCRs in retrogenic mice.
    Sprouse ML; Blahnik G; Lee T; Tully N; Banerjee P; James EA; Redondo MJ; Bettini ML; Bettini M
    J Immunol Methods; 2016 Dec; 439():29-36. PubMed ID: 27589924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell receptor-transgenic primary T cells as a tool for discovery of leukaemia-associated antigens.
    Ivanov R; Hol S; Aarts TI; Hagenbeek A; Ebeling SB
    Clin Exp Immunol; 2006 Jan; 143(1):78-84. PubMed ID: 16367937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, sequencing and expression of the bovine CD3 epsilon and TCR-zeta chains, two invariant components of the T-cell receptor complex.
    Hagens G; Galley Y; Glaser I; Davis WC; Baldwin CL; Clevers H; Dobbelaere DA
    Gene; 1996 Mar; 169(2):165-71. PubMed ID: 8647441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function.
    Zhang T; He X; Tsang TC; Harris DT
    Cancer Gene Ther; 2004 Jul; 11(7):487-96. PubMed ID: 15153936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.
    Udyavar A; Geiger TL
    Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):335-46. PubMed ID: 20680493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.